PositiveID Corp. (PSID) Offers Update on Initial Deployment of FDA-cleared iGlucose™ System
PositiveID, developer of advanced technologies for diabetes management and rapid medical testing, as well as airborne bio-threat detection systems for America's homeland defense, today issued an update of the progress of the initial deployment of its FDA-cleared iglucose™ mobile health system for diabetes management. The iglucose system collects and transmits stored data from a variety of FDA-cleared blood glucose meters to a secure database via wireless cellular technology. The system is currently being trialed by three large companies and was also recently trialed by a leading global pharmaceutical company. "Many large organizations are currently trialing iglucose, from one of the…